Here's the live share price of Strides Pharma Science along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Strides Pharma Science has gained 6.43% CAGR. Over the past year, the corresponding return has been -39.91%.
Strides Pharma Science’s current P/E of 23.73x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Strides Pharma Science | 14.78 | 14.10 | 6.96 | 46.85 | -39.91 | 44.55 | 6.43 |
| Sun Pharmaceutical Industries | -0.57 | 3.28 | -0.92 | -7.60 | -8.61 | 18.48 | 29.21 |
| Divi's Laboratories | 2.65 | 18.41 | 2.45 | 10.85 | 14.73 | 23.31 | 17.28 |
| Cipla | -5.18 | -0.81 | -3.38 | -1.58 | -3.32 | 8.79 | 14.87 |
| Torrent Pharmaceuticals | -0.80 | -0.38 | -5.14 | 9.01 | 10.85 | 29.10 | 22.78 |
| Dr. Reddy's Laboratories | -6.61 | -3.78 | -5.65 | 1.37 | -5.90 | 10.60 | 4.30 |
| Mankind Pharma | -2.15 | -2.43 | -7.34 | -0.11 | -10.77 | 18.66 | 10.81 |
| Zydus Lifesciences | -3.15 | -1.79 | 0.41 | 10.00 | -2.78 | 30.95 | 18.88 |
| Lupin | 1.95 | -0.64 | 2.09 | -4.31 | -9.93 | 41.27 | 16.64 |
| Aurobindo Pharma | 4.93 | 4.74 | -0.20 | -6.06 | -18.43 | 28.36 | 8.42 |
| Alkem Laboratories | -0.73 | 0.83 | 9.42 | 8.53 | -4.81 | 20.39 | 15.68 |
| Abbott India | -3.15 | -2.92 | -15.75 | -5.70 | 0.08 | 14.62 | 13.33 |
| Glenmark Pharmaceuticals | 3.96 | -3.48 | -11.38 | 37.43 | 11.65 | 67.21 | 31.92 |
| Laurus Labs | 3.16 | 9.45 | 9.18 | 53.86 | 94.04 | 28.05 | 25.98 |
| Biocon | 3.58 | 7.36 | -4.88 | 16.74 | 17.67 | 11.37 | -1.64 |
| GlaxoSmithKline Pharmaceuticals | -4.58 | -2.61 | -16.91 | -8.00 | -3.51 | 23.97 | 13.24 |
| Anthem Biosciences | -1.31 | -7.94 | -6.37 | -2.73 | -2.73 | -0.92 | -0.55 |
| Ipca Laboratories | 0.17 | -4.35 | -13.80 | -7.87 | -20.02 | 11.98 | 2.00 |
| Gland Pharma | -0.60 | -2.66 | -6.66 | 37.25 | 16.79 | 2.61 | 1.15 |
| Ajanta Pharma | 2.22 | 2.85 | -10.32 | -4.54 | -19.69 | 23.86 | 18.63 |
Over the last one year, Strides Pharma Science has declined 39.91% compared to peers like Sun Pharmaceutical Industries (-8.61%), Divi's Laboratories (14.73%), Cipla (-3.32%). From a 5 year perspective, Strides Pharma Science has underperformed peers relative to Sun Pharmaceutical Industries (29.21%) and Divi's Laboratories (17.28%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 813.37 | 833.64 |
| 10 | 808.65 | 826.25 |
| 20 | 818.57 | 827.27 |
| 50 | 852.95 | 838.79 |
| 100 | 859.26 | 835.31 |
| 200 | 758.38 | 839.72 |
In the latest quarter, Strides Pharma Science saw a drop in promoter holding to 27.87%, while DII stake decreased to 12.98%, FII holding rose to 28.51%, and public shareholding moved up to 30.62% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 33,40,936 | 0.94 | 274.16 | |
| 14,22,000 | 1.26 | 116.69 | |
| 7,35,028 | 0.23 | 60.32 | |
| 3,82,997 | 0.24 | 31.43 | |
| 3,66,350 | 0.5 | 30.06 |
* Excluding Index & Arbitrage Funds
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Date Time | Announcement |
|---|---|
| Nov 01, 2025, 2:26 AM IST | Strides Pharma Scien - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Oct 31, 2025, 6:37 PM IST | Strides Pharma Scien - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Oct 31, 2025, 6:35 PM IST | Strides Pharma Scien - Outcome Of Board Meeting - Un-Audited Financial Results (Consolidated & Standalone) For The Quarter An |
| Oct 25, 2025, 3:17 AM IST | Strides Pharma Scien - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Oct 25, 2025, 12:26 AM IST | Strides Pharma Scien - Board Meeting Intimation for Intimation Regarding Board Meeting Under Regulation 29 Of SEBI (Listing O |
Strides Pharma Science Ltd. is a Public Limited Listed company incorporated on 28/06/1990 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24230MH1990PLC057062 and registration number is 057062. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 2139.42 Cr. and Equity Capital is Rs. 92.16 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Strides Pharma Science is ₹934.65 as on Oct 31, 2025.
The Strides Pharma Science is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Strides Pharma Science is ₹8,614.92 Cr as on Oct 31, 2025.
Today’s highest and lowest price of Strides Pharma Science are ₹979.00 and ₹830.45.
The 52-week high/low is the highest and lowest price at which Strides Pharma Science stock has traded in the past 52-week or nearly a year. The 52-week high of Strides Pharma Science is ₹1,652.70 and 52-week low of Strides Pharma Science is ₹530.70 as on Oct 31, 2025.
The Strides Pharma Science has shown returns of 9.97% over the past day, 14.1% for the past month, 6.96% over 3 months, -39.91% over 1 year, 44.55% across 3 years, and 6.43% over 5 years.
P/E ratio of and PB ratio of Strides Pharma Science are 23.73 and 3.79 on Oct 31, 2025. While the company gives a dividend yield of 0.43 per annum.